EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recurrence of primary Sclerosing Cholangitis after liver transplantation: Challenges, insights, and future directions

Hirushi Ravinga Weeraratne, Samith Minu Alwis, Madhavi-Priya Singh, Avik Majumdar, Marcos Vinicius Perini

Digestive and Liver Disease · 2026

DOI: 10.1016/j.dld.2026.03.016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digestive and Liver Disease, 2026. Verfasst von Hirushi Ravinga Weeraratne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Liver Transplantation, Cholangitis, Sclerosing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary sclerosing cholangitis (PSC) is an immune-mediated fibro-obliterative disease of the biliary tree which culminates in biliary cirrhosis and decompensated liver failure. Increasing in incidence, PSC comprises a growing indication for liver transplantation (LT) with LT remaining the only proven life-prolonging therapy in patients with PSC. Recurrence of PSC (rPSC) after LT is however poorly understood and poses a further challenge due to heterogeneity in diagnostic criteria and proposed negative associations with graft failure and overall survival. This review explores the current literature surrounding rPSC including diagnosis, epidemiology, therapeutic options and patient outcomes. We discuss the challenges in the management of rPSC. Given the scarcity of literature and frequency of re-transplantation for rPSC, further clinical investigation is necessary to identify risk factors and effective therapies in this cohort of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCholangitis, SclerosingHumansRecurrenceRisk Factors

Stichwörter der Autor:innen

Graft failureLiver transplantationPrimary sclerosing cholangitisRecurrenceSurvival

Autor:innen und Institutionen

  • Department of Surgery (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Medicine (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Surgery (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia; Victorian Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia. Electronic address: marcos.perini@unime…

Zitieren

APA

Weeraratne, H. R., Alwis, S. M., Singh, M. P., Majumdar, A., & Perini, M. V. (2026). Recurrence of primary Sclerosing Cholangitis after liver transplantation: Challenges, insights, and future directions. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.03.016

Vancouver

Weeraratne HR, Alwis SM, Singh MP, Majumdar A, Perini MV. Recurrence of primary Sclerosing Cholangitis after liver transplantation: Challenges, insights, and future directions. Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.03.016

BibTeX
@article{Weeraratne2026,
  author = {Weeraratne, Hirushi Ravinga and Alwis, Samith Minu and Singh, Madhavi-Priya and Majumdar, Avik and Perini, Marcos Vinicius},
  title = {Recurrence of primary Sclerosing Cholangitis after liver transplantation: Challenges, insights, and future directions},
  journal = {Digestive and Liver Disease},
  year = {2026},
  doi = {10.1016/j.dld.2026.03.016}
}
Kostenlos starten →